Shares of Verastem rose late Thursday after interim data from the company’s trial evaluating a combination therapies to treat pancreatic cancer showed a...
U.S. regulators took a major step forward Thursday toward green-lighting a spot ether exchange-traded product that could potentially lead to mainstream adoption of...